Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Breast 1

Conditions

Advanced Breast Cancer 1

Interventions

Surveys and Questionnaires 79 Blood Specimen Collection 67 palbociclib 40 Trastuzumab 34 Drug Therapy 30 Letrozole 29 Anastrozole 27 Radiotherapy 26 Immunohistochemistry 26 Mastectomy, Segmental 22 Amplified Fragment Length Polymorphism Analysis 22 Fulvestrant 21 Biopsy 21 exemestane 20 Tamoxifen 20 Interviews as Topic 20 Gene Expression Profiling 20 Magnetic Resonance Spectroscopy 19 ribociclib 18 Specimen Handling 18 Mastectomy 18 Neoadjuvant Therapy 17 Paclitaxel 16 High-Energy Shock Waves 16 Capecitabine 16 trastuzumab deruxtecan 15 Mammography 15 Psychiatric Rehabilitation 14 Polymerase Chain Reaction 13 Observation 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Safety × Breast × Clear all

NCT06926088 2025-04-13

CAMELIA

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡